Ryan White Care Hepatitis C & B Language
NATAP Webinars
HIV Treatment Strategies & Prevention; CROI 2025
Friday, April 4th, 2025 - 12:30pm
Click here to Register
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
CROI:
10-Minute Targeted Geriatric Assessment identifies vulnerable and frail older persons with HIV
- (04/10/25)
CROI:
Characteristics and Treatment Outcomes of People With HIV Prescribed Fostemsavir in The Trio Cohort: increased CD4
- (04/07/25)
CROI:
Racial Inequity in Initiation of Semaglutide Therapy Among People With HIV in Care Across the US
- (04/07/25)
CROI:
Patterns of Social and Biological Risk Factors in People with HIV and Risk of Cardiovascular Disease
- (04/07/25)
CROI:
People with HIV at high cardiovascular risk were undertreated with statins
- (04/07/25)
CROI:
Impact of Switching from DTG/3TC to BIC/FTC/TAF on Weight, Cholesterol and Inflammation in HIV
- (04/07/25)
CROI:
Impact of ART Simplification with Dolutegravir and Lamivudine on the HIV Reservoirs
- (04/07/25)
CROI:
Statin Effect Heterogeneity on Plaque Volume & Composition in the REPRIEVE Mechanistic Substudy: non calcified plaque reduction
- (04/07/25)
CROI:
Effect of 12-month Switch to Dual cART on HIV reservoir, T-cell homeostasis, Gut and Mitochondrial Damage
- (04/07/25)
CROI:
Integrase Inhibitor Versus Protease Inhibitor Based Therapy for People with Advanced HIV Disease (LAPTOP)
- (04/07/25)
CROI:
Switch to DTG/3TC vs BIC/FTC/TAF (PASO-DOBLE study): Efficacy and Weight Changes by Predefined Subgroups
- (04/07/25)
CROI:
New HIV Drugs at CROI 2025
- (04/07/25)
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
- (12/18/24)
More Hep D Articles...
Aging & Perinatally Acquired HIV
CROI:
Thwarting a protein in the hope of a better quality of life: fostemsavir gp120 aging study
- (04/07/25)
CROI:
Plasma Inflammation is Associated With Brain Cellularity in Diffusion-Based Spectral Imaging in HIV
- (03/24/25)
More Aging & HIV Articles...
PrEP
CROI:
The Influence of Racialized Economic Segregation on Unmet HIV prevention Needs in the Real World
- (03/29/25)
CROI:
PURPOSE 1: Preference for Twice-Yearly Injection vs Daily Oral Pills for HIV PrEP in Cisgender Women
- (03/29/25)
CROI:
The Association between PrEP-to-Need Ratio and HIV Incidence Rates in the United States: County-level Analyses From 2012 to 2021
- (03/29/25)
CROI:
Pre-exposure Prophylaxis Uptake in High Female-to-Male HIV Prevalence Regions in the US
- (03/29/25)
CROI:
Suboptimal laboratory testing of PrEP users - United States, 2022-2023
- (03/29/25)
CROI:
Qualitative Assessment of Acceptability and Preferences for Injectable and Oral PrEP in PURPOSE 1
- (03/29/25)
CROI:
Understanding NLRP3 Inflammasome Activation at the Intersection of HIV and Aging
- (03/29/25)
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
CROI:
Preclinical Pharmacokinetic Assessment of a Long-acting Solid Injectable for Hepatitis C Virus
- (03/22/25)
CROI:
Direct Acting Antiviral Initiation among People with HIV and HCV in North America: Factors Driving the Treatment Gap
- (03/22/25)
CROI:
Comorbidities among Medicaid Enrollees with Chronic Hepatitis C, 2016-2020
- (03/20/25)
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
CROI:
HIV-1 Resistance Analysis of ALLIANCE Open-Label Extension: Switch to B/F/TAF in People With Both HIV-1 and HBV
- (03/24/25)
CROI:
HIV-1 Resistance Analysis of Treatment-Naïve People With HIV and HBV Receiving B/F/TAF or DTG + F/TDF
- (03/24/25)
CROI:
Highly durable seroprotection with HepB-CpG vaccine in people with HIV (PWH): ACTG A5379 (BEeHIVe)
- (03/22/25)
CROI:
HBsAg SEROCLEARANCE IN HIV AND HBV-COINFECTED PATIENTS IN THE ERA OF TENOFOVIR-CONTAINING THERAPY
- (03/20/25)
CROI:
Hepatitis B Reactivation in PWH With Isolated Anti-Core Pattern on Therapies Excluding Tenofovir
- (03/20/25)
CROI:
HBV Reactivation Post-switch to HBV-inactive ART: A Scoping Review
- (03/20/25)
More Hep B Articles...
Fatty Liver, NAFLD, NASH
CROI:
Cardiometabolic Effects of Semaglutide in People With HIV: The Slim Liver Study
- (04/07/25)
CROI:
Lipidomics of metabolic dysfunction-associated steatotic liver disease post-HCV eradication in PWH
- (03/20/25)
CROI:
Liver Steatosis progression with Integrase Inhibitors in HIV Adults in Low-/Middle-Income Countries
- (03/20/25)
CROI:
Semaglutide Improves Steatohepatitis in People With HIV: The SLIM LIVER Study
- (03/20/25)
CROI:
Evaluation of different non-invasive models in assessing lean MAFLD among PLWH: High rates of Lean MAFLD
- (03/20/25)
CROI:
Effects of Semaglutide on Gut Microbiota in People With HIV: The SLIM LIVER Study
- (03/20/25)
CROI:
Determinants of Steatotic Liver Disease Among People with HIV in Europe and Australia
- (03/20/25)
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
https://academicmedicaleducation.com/meeting/2nd-african-workshop-women-hiv-2025
https://academicmedicaleducation.com/meeting/2nd-menopause-hiv-webinar-2025
https://www.croiconference.org
https://academicmedicaleducation.com/meeting/15th-international-workshop-women-hiv-2025
https://acthiv.org/
https://ddw.org/
https://www.easlcongress.eu/
https://asm.org/Events/ASM-Microbe/Home
IAS 2025, the 13th IAS Conference on HIV Science,
Kigali, Rwanda, July 13 to 17,
pre-conferences on 13 July.
https://www.iasociety.org/conferences/ias2025
https://academicmedicaleducation.com/meeting/26th-international-workshop-clinical-pharmacology-hiv-hepatitis-and-other-antiviral-drugs
https://academicmedicaleducation.com/meeting/11th-international-viral-hepatitis-elimination-meeting-ivhem-2025
https://academicmedicaleducation.com/meeting/8th-conference-liver-disease-africa-colda-2025
https://www.eacsociety.org/european-aids-conference/european-aids-conference/
https://idweek.org/
https://academicmedicaleducation.com/meeting/16th-international-workshop-hiv-aging-2025
https://www.aasld.org/the-liver-meeting
https://neurohiv.com/
